#leo pharma

Collection of leo pharma news, found 8 news.

LEO Pharma announces FDA approval of Adbry™ (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis

LEO Pharma announces FDA approval of Adbry™ (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis

  • 28th December 2021

LEO Pharma A/S, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration ...

Article Published in JAMA Dermatology Shows Long-term Effectiveness of Ingenol Mebutate in Treating Actinic Keratosis

Article Published in JAMA Dermatology Shows Long-term Effectiveness of Ingenol Mebutate in Treating Actinic Keratosis

  • 21st March 2013

-Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 monthsAn analysis of ...

LEO Pharma Puts Patients at the Heart of Innovation

LEO Pharma Puts Patients at the Heart of Innovation

  • 20th March 2013

-      LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation ...

Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis

Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis

  • 19th March 2013

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...

LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement

LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement

  • 26th February 2013

-     LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...

International Study Highlights Need to Support Patients With Psoriasis

International Study Highlights Need to Support Patients With Psoriasis

  • 30th September 2012

-     * LEO Pharma has conducted the first truly large scale international study informed by both ...

LEO Pharma Initiates Global Search for New Partners

LEO Pharma Initiates Global Search for New Partners

  • 15th June 2012

-         LEO Pharma is now actively searching for new global or territorial ...

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

  • 7th June 2011

-        - NOT INTENDED FOR US MEDIA    - Ingenol Mebutate is an ...